Babu Yarlagadda S

Avg. Two Year Performance

No purchase track record

20% Avg. Sale Return

10% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	5%	4%	(4%)	38%	20%
Sale Success Rate	3 of 7	4 of 7	3 of 7	5 of 7	4 of 7

BioCryst Pharmaceuticals Inc.

Drugs » Biotechnology

Chief Discovery Officer:

Holdings: 298.54K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--